oxybutynin has been researched along with Malignant Melanoma in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| " As a worst-case scenario for consequences of repeated application on neoplastic growth, the melanin-binding drug, rasagiline, was used in a transdermal formulation applied directly to a human-derived melanoma to determine the effects on tumor growth." | 7.78 | Comparison of oral and transdermal administration of rasagiline mesylate on human melanoma tumor growth in vivo. ( Arjmand, FM; Christianson, C; Dines, K; Hamlin, R; Huang, B; Meier-Davis, SR; Nagata, T; Shudo, J; Wen, J, 2012) |
| " As a worst-case scenario for consequences of repeated application on neoplastic growth, the melanin-binding drug, rasagiline, was used in a transdermal formulation applied directly to a human-derived melanoma to determine the effects on tumor growth." | 3.78 | Comparison of oral and transdermal administration of rasagiline mesylate on human melanoma tumor growth in vivo. ( Arjmand, FM; Christianson, C; Dines, K; Hamlin, R; Huang, B; Meier-Davis, SR; Nagata, T; Shudo, J; Wen, J, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, X | 1 |
| Li, H | 1 |
| Zhou, D | 1 |
| Chen, Z | 1 |
| Gu, Z | 1 |
| Meier-Davis, SR | 1 |
| Dines, K | 1 |
| Arjmand, FM | 1 |
| Hamlin, R | 1 |
| Huang, B | 1 |
| Wen, J | 1 |
| Christianson, C | 1 |
| Shudo, J | 1 |
| Nagata, T | 1 |
2 other studies available for oxybutynin and Malignant Melanoma
| Article | Year |
|---|---|
Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
Topics: Animals; Antibodies, Monoclonal; B7-H1 Antigen; Disease Models, Animal; Drug Delivery Systems; Extra | 2020 |
Comparison of oral and transdermal administration of rasagiline mesylate on human melanoma tumor growth in vivo.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Antineoplastic Agents; Disease Models, Ani | 2012 |